Polyphenolic Nanomedicine Regulating Mitochondria REDOX for Innovative Cancer Treatment
Pharmaceutics · 23.07.2024 · 16 (8) · 972
DOI: 10.3390/pharmaceutics16080972 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.07.2024. Verfasst von Mingchuan Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou 310008, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research and Development Program of Zhejiang, National Natural Science Foundation of China, the Anhui Provincial Natural Science Foundation.
Abstract (Originalsprache)
Cancer remains a highly lethal disease globally. The approach centered on REDOX-targeted mitochondrial therapy for cancer has displayed notable benefits. Plant polyphenols exhibit strong REDOX and anticancer properties, particularly by affecting mitochondrial function, yet their structural instability and low bioavailability hinder their utility. To overcome this challenge, researchers have utilized the inherent physical and chemical characteristics of polyphenols and their derivatives to develop innovative nanomedicines for targeting mitochondria. This review examines the construction strategies and anticancer properties of various types of polyphenol-based biological nanomedicine for regulating mitochondria in recent years, such as polyphenol self-assembly, metal–phenol network, polyphenol–protein, polyphenol–hydrogel, polyphenol–chitosan, and polyphenol–liposome. These polyphenolic nanomedicines incorporate enhanced features such as improved solubility, efficient photothermal conversion capability, regulation of mitochondrial homeostasis, and ion adsorption through diverse construction strategies. The focus is on how these polyphenol nanomedicines promote ROS production and their mechanism of targeting mitochondria to inhibit cancer. Furthermore, it delves into the benefits and applications of polyphenolic nanomedicine in cancer treatments, as well as the challenges for future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou 310008, China.
- Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
- Hangzhou Academy of Agricultural Sciences, Hangzhou 310008, China.
- Anhui Province Green Food Collaborative Technology Service Center for Rural Revitalization, School of Biological and Food Engineering, Hefei Normal University, Hefei 230601, China.
ORCID-Profile: Xiangchun Zhang
Förderung
- the Key Research and Development Program of Zhejiang
- National Natural Science Foundation of China
- the Anhui Provincial Natural Science Foundation
- the Innovative Program of Chinese Academy of Agricultural Sciences
- the Agriculture Research System of China of MOF and MARA
- Key Research and Development Program of Zhejiang
- Anhui Provincial Natural Science Foundation
- Innovative Program of Chinese Academy of Agricultural Sciences
Zitieren
APA
Yang, M., He, Y., Ni, Q., Zhou, M., Chen, H., Li, G., Yu, J., Wu, X., & Zhang, X. (2024). Polyphenolic Nanomedicine Regulating Mitochondria REDOX for Innovative Cancer Treatment. Pharmaceutics, 16(8), 972. https://doi.org/10.3390/pharmaceutics16080972
Vancouver
Yang M, He Y, Ni Q, Zhou M, Chen H, Li G, et al. Polyphenolic Nanomedicine Regulating Mitochondria REDOX for Innovative Cancer Treatment. Pharmaceutics. 2024;16(8):972. doi:10.3390/pharmaceutics16080972
BibTeX
@article{Yang2024,
author = {Yang, Mingchuan and He, Yufeng and Ni, Qingqing and Zhou, Mengxue and Chen, Hongping and Li, Guangyun and Yu, Jizhong and Wu, Ximing and Zhang, Xiangchun},
title = {Polyphenolic Nanomedicine Regulating Mitochondria REDOX for Innovative Cancer Treatment},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {8},
pages = {972},
doi = {10.3390/pharmaceutics16080972}
}
EUVIMED